Background: Motion due to respiration may challenge dose prediction of dose calculation
Background
The calculation of photon field dose distributions within lowdensity inhomogeneity in the presence of motion artefacts can be a challenge for algorithms in clinical treatment planning systems (TPS). Such clinical cases with low-density inhomogeneity and motion artefacts are common for lung stereotactic body radiation therapy (SBRT) treatments. During lung SBRT planning, dose calculations are performed on average intensity projected (AIP) images derived from four-dimensional computed tomography (4DCT) images. 1 This accounts for any tumour motion due to respiration during treatment. As high doses are being delivered in few fractions during lung SBRT, dosimetric precision for dose calculations are relevant and very important. Most inhomogeneity studies compare calculated depth doses within static inhomogeneous phantoms. [2] [3] [4] [5] [6] [7] [8] [9] [10] Other respiratory motion studies done were only limited to the superior-inferior tumour motion. 11, 12 A controlled depth dose study of external surface motion and anterior-posterior tumour motion will contribute to the understanding of calculated dose distributions under respiratory motion. Furthermore, small photon fields such as 2 × 2 cm 2 can impose problems due to lack of lateral charge particle equilibrium and changes in energy spectrum. Under the presence of motion artefacts, small photon fields and low-density medium such as lung, the limitations of clinical dose calculation algorithms can be tested.
Previous inhomogeneous phantom studies compared the performance of Anisotropic Analytical Algorithm (AAA) and Acuros XB dose calculation (AXB) algorithm (both from Varian Medical Systems, Inc., Palo Alto, CA), version 10.0.28, against Monte Carlo (MC) simulation. It was found that the accuracy of the algorithms depends on the photon beam energy, field size and density of the medium. [2] [3] [4] [5] [6] [7] [8] The recent release of an improved version for both AAA and AXB algorithms, version 13.6.23, highlighted key changes in the dose prediction performance, especially in how each algorithm account for inhomogeneities.
Aim
To our knowledge thus far, no was study done for the depth dose differences between a full MC simulation and two versions of AAA and AXB algorithm under the presence of a moving tumour and chest wall. This study will systematically investigate the comparison of MC calculated depth doses from an independently modelled treatment head against independently simulated 6X depth doses calculated using AAA and AXB algorithm, versions 10.0.28 and 13.6.23. Dose calculations were done on the QUASAR respiratory motion phantom (Modus Medical Devices Inc., London, ON). Electron Gamma Shower Monte Carlo simulation package developed by the National Research Council of Canada (EGSnrc) 13 was used for the full Monte Carlo simulation. MC simulated data were validated against measurement under homogenous condition in water, as well as inhomogeneous condition in a static lung phantom. MC was used as a benchmark for depth dose comparison in the respiratory phantom for this study. Anterior and lateral beam depth doses were compared to investigate depth dose differences for both superior-inferior and anterior-posterior motion of the tumour.
3.
Materials and methods
Full Monte Carlo simulation model
Monte Carlo calculations were done using EGSnrc V4-r2.4.0, consisting of BEAMnrc and DOSXYZnrc user codes developed by the National Research Council of Canada. A Linux-based computer cluster which comprised of 12 Intel Xeon central processing units (CPUs) with processing speeds of 2.67 or 3.4 GHz and a total of 40 GB of RAM was used for the calculations.
Phase space files for a Varian Clinac iX linear accelerator treatment head (Varian Medical Systems Inc., Palo Alto, CA) of 6 MV photon beam for field sizes 2 × 2 cm 2 , 4 × 4 cm 2 and 10 × 10 cm 2 (100 cm SSD) were generated using BEAMnrc. The initial electron beam was 6.1 MeV with focal spot width of 0.3 cm at full width at half maximum. The energy spectrum of the bremsstrahlung beam was matched with the phase space file released by International Atomic Energy Agency (IAEA) phase space database. 14 Computational efficiency was increased using variance reduction technique such as directional bremsstrahlung splitting (DBS). The global photon and electron cut-off energies were 0.01 MeV and 0.7 MeV respectively. The splitting number was set to 1000 and the electron splitting was performed in the lower layers of the flattening filter as recommended. 15 Range rejection was turned on with varying ECUTRR and was considered for electrons with energy less than 2 MeV (ESAVE GLOBAL = 2). 16 EXACT was chosen for the boundary crossing and electron step algorithms. Both BEAMnrc and DOSXYZnrc usercodes used similar settings. All DOSXYZnrc dose calculations were performed using 1 × 10 10 histories with statistical uncertainties below 1%. EGSnrc calculation voxel size was set similar to Eclipse treatment planning system (TPS) (Varian Medical Systems, Palo Alto, CA) calculation grid size of 0.25 cm. The uniform calculation grid size across considered algorithms was an improvement from the previous inhomogeneity dose modelling done by Zvolanek et al. 17 
3.2.
AAA and AXB algorithm AAA and AXB algorithm were configured for Varian Clinac iX using Eclipse TPS. Calculations were done across AAA version 10.0.28 (AAAv10.0), AAA version 13.6.23 (AAAv13.6), AXB algorithm version 10.0.28 (AXBv10.0) and AXB algorithm version 13.6.23 (AXBv13.6) against MC simulation. Dose to medium (D m ) reporting mode was chosen for AXBv10.0 and AXBv13.6, similar to previous studies. 6, 7, [18] [19] [20] From here on forth, the terms "AAA" and "AXB algorithm" will be used to describe both versions of their algorithms (i.e. AAAv10.0, AAAv13.6 and AXBv10.0, AXBv13.6 respectively). Depth dose profiles for field sizes 2 × 2 cm 2 , 4 × 4 cm 2 and 10 × 10 cm 2 were calculated with calculation grid size of 0.25 cm. 
CT calibration curve
The CT calibration curve in Eclipse TPS was calibrated using a multi-plug CIRS ® phantom 062 (Computerized Imaging Reference Systems, Norfolk, VA, USA). Both AXBv10.0 and AXBv13.6 refers to the same CT calibration curve for the HU value to mass density relationship in each voxel of the image grid. For consistency, the same CT calibration curve was configured in MC calculations. Cross section data for air, lung, adipose, muscle, cartilage and bone were generated according to AXBv10.0 material cross section data using PEGS in EGSnrc. 13, 21 The HU value to relative electron density calibration curve for AAA calculations was also calibrated using the same phantom.
Mass density to material mapping
In order to perform dose calculations, AXB algorithm and EGSnrc require the macroscopic cross section for each material in its computational grid. 19 The algorithms, however, assign the material based on the HU value of each voxel differently. AXBv13.6 allows the overlapping of mass density ranges in CT to material mapping 22 ( Fig. 1 ). In contrast, EGSnrc and AXBv10.0 do not allow the overlapping of mass density ranges. The mass density to material mapping for EGSnrc was configured to be the same as AXBv10.0, except with the addition of air material in EGSnrc. The air material added was identical to AXBv13.6. This was similar to previous work done by Ojala et 
Variations in HU profile under static and respiratory motion
The moving lung tumour and chest wall causes motion artefacts, forming HU value gradients. This causes several regions of the lung phantom to exhibit contrasting HU values relative to the denser tumour polyoxymethylene sphere, 25 as shown in Fig. 2a and b. The AIP HU profile in the anterior beam direction shows less CT contrast and greater similarities to static HU profile. HU profile differences could only be observed for the superior-inferior tumour motion, with only a minor difference between HU value gradients.
In the lateral beam direction, the moving chest wall had a HU value gradient between −900 and −100 HU, representing the highest CT contrast due to motion.The moving chest wall and tumour dimensions were enlarged by twice the motion amplitude in the lateral beam AIP HU profile, with ill-defined boundaries between different mediums.
Validation of MC doses under homogeneity condition
MC depth dose profiles for field sizes 2 × 2 cm 2 , 4 × 4 cm 2 and 10 × 10 cm 2 were verified against an IBA PFD Photon Diode Dosimetry detector (IBA/Scanditronix Medical AB, Uppsala, Sweden) in water. The experimental setup comprises of a 30 × 30 × 30 cm 3 water phantom placed on the patient couch with the linear accelerator gantry at 270 • . Correspondingly, water phantom was simulated using H2O700ICRU with a voxel size of 0.25 × 0.25 × 0.25 cm 3 in DOSXYZnrc. MC simulated data agreed with measured data and passed gamma analysis with passing criteria of 1%/1 mm for the required field sizes in this study 26 (Fig. 3) .
Validation of MC calculated doses under inhomogeneous condition
MC depth dose profiles for field sizes 2 × 2 cm 2 , 4 × 4 cm 2 and 10 × 10 cm 2 were validated under inhomogeneous condition against film dosimetry. In-vivo measurements were done using Gafchromic TM External Beam Therapy 3(EBT3) films (International Specialty Products, Wayne, New Jersey). Absolute dosimetry was obtained by calibration of the required films to a known dose distribution during each measurement session. For each measurement position, the average data from two pieces of films was evaluated to increase the accuracy of the measured plane. 11, 27 Films were scanned at 75 dots per inch (dpi) using Epson Expression 11000XL scanner (Seiko Epson Corporation, Nagano, Japan) at 15 h after the irradiation. Evaluation of film measurements was done using SNC Patient software (version 6.2.1, Sun Nuclear Corp., Melbourne, FL, USA). Fig. 4a shows the experimental setup of the static lung phantom used. It consists of composite cork slabs sandwiched between 4 cm thick CIRS plastic water (Computerized Imaging Reference Systems Plastic Water Diagnostic Therapy, Norfolk, VA, USA) above and below. 14 pieces of 1 cm thick, composite cork slabs, with density 0.27 g/cm 3 were used. 14 film measurement positions were done along the central axis at 1.5 cm, 2 cm, 3 cm, 4 cm, 6 cm, 8 cm, 11 cm, 14 cm, 16 cm, 18 cm, 18.5 cm, 19 cm, 20 cm and 21 cm below the surface. Films were placed along the central axis at each position per measurement, so as to prevent overshadowing. The lung phantom was simulated in MC according to the weight fractions of the elements within the materials, as reported by Ramaseshan et al. 28 and Chang et al. 29 Calculation voxel size was 0.25 × 0.25 × 0.25 cm 3 . Results show that MC simulated data agreed with film measured data to within 2% tolerance for the field sizes investigated (Fig. 4b) .
3.5.
QUASAR respiratory motion phantom setup QUASAR respiratory motion phantom was configured to 1 cm amplitude sinusoidal respiratory motion, with a breathing frequency of 0.25 Hz. This corresponds to an average patient breathing amplitude and rate of 15 breaths/min. 30 The cedar wood lung insert holds a 3 cm diameter polyoxymethylene sphere which simulates the target lung tumour (Fig. 5) . Dental modelling wax was moulded to the lung phantom insert to create a 4 cm chest wall. The dental modelling wax used (Metrowax, Metrodent Limited, United Kingdom) is a tissue equivalent material that allows the simulation of the buildup dose before the cedar wood lung phantom insert. 31 Table 1 shows the density and material composition of the QUASAR lung insert materials.
3.6.
Image acquisition 4DCT images were acquired using a single-source multidetector CT scanner (Siemens Somatom Definition AS, Siemens Medical Solutions, Forchheim, Germany). The 4DCT images using 1 mm slice thickness, 0.5 s per rotation and 0.1 pitch was obtained to construct the AIP images of the phantom. AIP images were obtained by averaging the ten phases of gated 4DCT images based on the helical Computed Tomography (CT) images. 35 These phases were obtained from the respiratory signal using the real-time position management optical system of the 4DCT (RPM; Varian Medical Systems, Palo Alto, CA).
Beam delivery and normalisation
6 MV photon beam was planned orthogonally at 100 cm fixed source to surface distance (SSD) setup when the lung insert is in the equilibrium position. The anterior beam was delivered orthogonal to the superior-inferior motion. The lateral beam was delivered in the direction of anterior-posterior motion with the moving chest wall, as shown in Fig. 6 . For anterior beams, central axis depth dose profiles were normalised to the dose at 3 cm depth within the static chest wall (Fig. 7) . For lateral beams, central axis depth dose profiles were normalised to the dose at 3 cm depth in the middle of the moving chest wall (Fig. 7) . Normalisation was done within the chest wall instead of at the centre of the tumour because of statistical fluctuation of calculated dose to tumour from the full MC dose profile. 
Results

Depth dose comparison in the anterior beam direction
Anterior depth doses are shown in Fig. 8 . By comparing with MC results, AAA tends to predict lower doses after static chest wall-lung interface for 2 × 2 cm 2 and 4 × 4 cm 2 and higher doses for all field sizes after lung-tissue interface. The greatest difference occurred for 10 × 10 cm 2 field, where deviations up to 7% was observed.
Predictions from AXB algorithm are generally within ±6% against MC simulation for all field sizes. The highest dose difference from MC was about 5.2% at lung-tissue interface in 2 × 2 cm 2 field by AXBv10. Deviations of AAA and AXB algorithm from MC calculations were within 7% even for the surface and buildup doses in the static chest wall. Results were consistent with previous static heterogeneous studies found. 2, 5, 6 Fig. 9 shows the comparison of AAA and AXB algorithm predicted depth doses against MC simulation in the lateral beam direction. The largest deviation of up to 105% from MC simulation occurs at the surface and buildup doses in 2 × 2 cm 2 for AAAv10.0. For 10 × 10 cm 2 , AXBv10.0 had 40% deviation in the surface and buildup doses from MC simulation. This disagreement of surface doses occurs at the high HU value gradient region in the moving chest wall. AAAv13.6 and AXBv13.6, on the contrary, shows agreement within 10% to MC simulation for all field sizes.
Depth dose comparison in the lateral beam direction
Excluding the surface and buildup regions, predictions by AAA algorithms show deviations in the secondary buildup regions such as the lung-tumour interfaces. This is especially so for field size 2 × 2 cm 2 (Fig. 9a) . Predictions by AXB algorithm within the phantom was in good agreement with MC simulations for all field sizes (within ±4%) even in the presence of the anterior-posterior tumour motion.
4.3.
Differences between the two versions of AAA and AXB algorithm Generally, differences for AAA and AXB algorithm predicted depth doses, excluding the surface and buildup doses, agrees well with each other to within ±1.5% (Fig. 10) . The surface and buildup doses for AAAv10.0 differs by up to 300% from AAAv13.6. Deviations in the surface and buildup doses between AXBv10.0 and AXBv13.6 differs by up to 60%.
Discussions
The depth dose comparison of a full MC simulation against dose calculations using AAA and AXB algorithm, versions 10.0.28 and 13.6.23 was investigated. The full MC simulation was verified under homogeneous and inhomogeneous conditions and was taken as the benchmark for this study.
Our results have highlighted large dose differences of up to 105% for AAAv10.0 and AXBv10.0 against the MC benchmark in the lateral beam direction. These differences were found in the region of the moving chest wall. Smaller dose differences were reported for AAAv13.6 and AXBv13.6. As discussed previously, the AIP CT of the moving chest wall has the highest HU value gradient due to the anterior-posterior motion. Previous studies claimed that anterior-posterior tumour motion was not clinically important because superior-inferior tumour motion was greater. 11, 36 However, this study shows that by having an experimental setup for anterior-posterior tumour motion, together with a 4 cm moving chest wall and 1 cm amplitude, it creates a controlled, yet challenging and demanding inhomogeneity condition. Results show that this setup was capable of differentiating the dosimetric capabilities of each algorithm and its respective versions. Anterior beam direction for superior-inferior tumour motion results was in fact, consistent with previous static inhomogeneous phantom and inhomogeneity dose modelling with respiratory motion studies 2, 5, 6, 11, 12, 17 but it was unable to differentiate the dosimetric capabilities of different algorithm versions. Dose differences in the surface and buildup regions in the The revelation of the dose prediction differences between two versions of AAA and AXB algorithm led to the investigation of the key changes made from version 10.0.28 to version 13.6.23. For AAAv13.6, it was found that a layer of water with a thickness of half CT slice spacing was no longer automatically added to the surface of the medium contour. [37] [38] [39] Subsequently, AAAv13.6 dose calculation was also corrected from producing "staircases" in the dose distribution for the buildup region, especially when very low densities were present in that region. 38 AAA calculates doses based on the CT image electron density using a water-based dose kernel. It does not consider the material's elemental compositions. The layer of water added to the surface of the medium contour by AAAv10.0 previously was to approximate the surface and buildup doses within a water medium. This may be a good approximation for a static chest wall as shown in Fig. 8 . However, for low HU value surfaces such as the moving chest wall, this approximation results in an overestimation of doses by AAAv10.0. Changes made in AAAv13.6 has shown that surface and buildup doses have better agreement with AXBv13.6 and MC calculations (Fig. 9) .
For AXB algorithm, it was found that air medium was newly included in the material library of AXBv13.6. 22 Furthermore, AXBv13.6 currently allows the overlapping of mass density ranges in CT to material mapping. 22, 21 Previously, AXBv10.0 assigns voxels with low HU values as low-density lung, in contrast to the air medium assigned by AXBv13.6. The difference in material assignment will result in different surface and buildup dose predictions due to different mass collision stopping powers and mass energy-absorption coefficients calculations. The overestimation of doses by AXBv10.0 in low HU value medium was also consistent with previous results from Ojala et al. and Onizuka et al. They compared the dose calculations of AXB version 10 against AXB version 11 within air medium. 23, 24 Other key changes for AAA and AXB algorithm version 13.6.23 include the improvement of image alignment and structure contouring in each voxel to calculation grid 37 and the changes made to the optimisation routine for the electron contamination model. The electron contamination model is sensitive to changes to dose deposition calculations and algorithm configuration routines. 40 The overall changes made to AAA and AXB algorithm in version 13.6.23 resulted in the agreement of dose prediction with MC benchmark as shown by the results in this study.
In addition, for small fields such as 2 × 2 cm 2 , AAA generally shows less agreement with AXB algorithm and MC simulations. Under small field conditions, there is an increase of lateral electronic disequilibrium along the central axis. AAA accounts tissue heterogeneity using the concept of radiological rectilinear scaling, where it simulates energy deposition as a function proportional to the ratio of the electron density of medium to water. 21 Rectilinear kernel scaling does not model small fields disequilibrium well as the different elemental composition of the simulated materials were disregarded. In reality, photon and electron scatter do not adhere to the rectilinear paths assumed in AAA. This is particularly pronounced in low-density lung material, where electron disequilibrium along the central axis becomes larger with smaller field sizes. 41 Furthermore, the previous study done by Fogliata et al. pointed out that AAA has an inability to model thin inhomogeneities accurately. 5 Changes in the HU value gradient (Fig. 2) were considered as several thin layers of heterogeneity as AAA assigns different electron densities to the voxel with respect to the voxel's HU value. These discrepancies were most noticeable in dose regions when there was a presence of a high HU value gradient as predicted by AAAv10.0 in Fig. 9 . This results in the discrepancies between AAA, MC and AXB algorithm.
The limitation of this study was not validating the considered depth doses by conducting dosimetric measurements. Although dosimetric measurements will prove to be a robust standard, in-vivo dosimetric measurements will introduce several other challenges. The low density of the lung insert, as well as small field sizes such as 2 × 2 cm 2 , causes potential loss of charged particle equilibrium. This will result in significant perturbation to the energy spectrum and the detector's dose response. Perturbation corrections must therefore be applied to correct the change in dose response. These corrections can only be accurately pre-calculated using MC simulation of the detector in the measured medium. Eventually, the accuracy of the detector's dose reading will still be dependent on the accuracy of the MC simulation. Furthermore, the position of measurement will be challenging to justify due to the 1 cm amplitude sinusoidal motion. For instance, the surface dose measurement of the moving chest wall at depth 0 cm will be difficult to obtain as the detector will most likely to measure doses at the equilibrium of the sinusoidal motion at depth 1 cm, resulting in greater dosimetric discrepancies.
Conclusions
AAAv13.6 and AXBv13.6 proved to be more competent in extreme inhomogeneous dose prediction than AAAv10.0 and AXBv10.0. Key changes between version 10.0.28 and version 13.6.23 were identified for both AAA and AXB algorithm. With different dose prediction response, physicists and clinicians should consider the version of clinical algorithm used for dose calculation of treatment plans with extreme inhomogeneities and motion artefacts.
